应用 |
A potent Hsp90 inhibitor for tumor cells |
产品介绍 |
17-AAG (Tanespimycin)是一种有效的HSP90抑制剂,IC50为5 nM,作用于从肿瘤细胞提取的HSP90比作用于从正常细胞提取的HSP90结合亲和力高100倍。 |
生化机理 |
17-AAG is a less toxic and more stable analog of geldanamycin. It acts an Hsp90 inhibitor that displays a 100-fold higher affinity for Hsp90 derived from tumor cells compared to Hsp90 from normal cells. 17-AAG inhibits Akt1 (Akt) activation and expression in tumors and synergizes with a number of anti tumor agents such as taxol2, cisplatin3, and UCN-014. 17-AAG causes the inactivation, destabilization and eventual degradation of HIF-1α5. 17-AAG is an inhibitor of K-Ras and N-Ras. |
别名 |
替拉替尼Telatinib;Tanespimycin;KOS 953;NSC 330507;Tanespimycin;CP 127374;BMS 722782;17-(Allylamino)-17-demethoxygeldanamycin;17-(Allylamino)geldanamycin;17-Demethoxy-17-allylamino geldanamycin;Geldanamycin |